Macias-Ceja Dulce C, Barrachina María D, Ortiz-Masià Dolores
Departamento de Farmacología and CIBER, Facultad de Medicina y Odontología, Universitat de Valencia, Valencia, Spain.
Departamento de Medicina, Facultad de Medicina y Odontología, Universitat de Valencia, Valencia, Spain.
Front Pharmacol. 2023 Jun 15;14:1170436. doi: 10.3389/fphar.2023.1170436. eCollection 2023.
Chronic inflammation is often associated with fibrotic disorders in which an excessive deposition of extracellular matrix is a hallmark. Long-term fibrosis starts with tissue hypofunction and finally ends in organ failure. Intestinal fibrosis is not an exception, and it is a frequent complication of inflammatory bowel disease (IBD). Several studies have confirmed the link between deregulated autophagy and fibrosis and the presence of common prognostic markers; indeed, both up- and downregulation of autophagy are presumed to be implicated in the progression of fibrosis. A better knowledge of the role of autophagy in fibrosis may lead to it becoming a potential target of antifibrotic therapy. In this review we explore novel advances in the field that highlight the relevance of autophagy in fibrosis, and give special focus to fibrosis in IBD patients.
慢性炎症常与纤维化疾病相关,其中细胞外基质的过度沉积是一个标志。长期纤维化始于组织功能减退,最终导致器官衰竭。肠道纤维化也不例外,它是炎症性肠病(IBD)的常见并发症。多项研究已证实自噬失调与纤维化之间的联系以及共同预后标志物的存在;事实上,自噬的上调和下调都被认为与纤维化的进展有关。更好地了解自噬在纤维化中的作用可能会使其成为抗纤维化治疗的潜在靶点。在本综述中,我们探讨了该领域的新进展,这些进展突出了自噬在纤维化中的相关性,并特别关注IBD患者的纤维化。